← FDA Drug Approvals (Drugs@FDA)

VORICONAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2024-04-03

Drug application

FDA Application #

ANDA218533

Application type

Abbreviated New Drug Application (Generic)

Brand name

VORICONAZOLE

Generic name

VORICONAZOLE

Active ingredients

VORICONAZOLE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ASPIRO

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2024-04-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown